While the spotlights are on biopharmaceuticals, the OSDF segment represents more than half of the 1100+ billion USD global pharmaceutical market. With sizeable markets in large developed countries but also large growth potential in some other parts of the world, it is the segment with the greatest opportunities for excipients suppliers.
In the current health crisis created by the virus, Kline anticipates, in the likely and best-case scenarios, the effects of disruptions on pharmaceutical production—and consequently on excipients demand caused by lockdowns and travel and transport bans across various countries—will be relatively short term. However, in the worst-case scenario, the supply disruptions due to extended lockdowns in various countries can have a more substantial impact on OSDF drug manufacturing and, in turn, significantly impact the demand growth of excipients globally.
Join this webinar to learn:
- What are the sales of specialty excipients in each analyzed region?
- What are the differences in consumption patterns between mature and “pharmerging”
- How are current formulation changes affecting the market of OSDF excipients?
- What does the post Covid19 future hold for the Specialty Excipients for Oral Solid
Dosage Forms market?